QuidelOrtho Looks to Sell Testing Unit at $1.5 Billion Valuation

businessmergers-acquisitionsrumors 2 posts · 2 accounts

Diagnostics firm QuidelOrtho Corp is exploring the sale of its point-of-care testing unit at a valuation of approximately $1.5 billion, according to a report by the Financial Times. The potential divestment aligns with a broader wave of private equity investment targeting healthcare providers and specialized testing platforms.

Point-of-care testing delivers rapid diagnostic results near the patient, distinguishing it from traditional centralized laboratory testing. The transaction would allow the San Diego-based company to refocus on its core laboratory diagnostics and supply chain operations while giving a financial sponsor direct exposure to the testing market. QuidelOrtho has not finalized the agreement.

From the sources (2 posts)

@business

Diagnostics firm QuidelOrtho Corp is looking to sell its point-of-care testing unit at a valuation of $1.5 billion, the Financial Times reported

@ftworldnews

QuidelOrtho looks to sell testing unit as PE circles healthcare companies

Market impact

12 small no near-term move expected

QDEL

Why it matters: An unconfirmed FT report that QuidelOrtho is exploring a ~$1.5B carve-out of its point-of-care unit is a single-name divestiture rumor that at most nudges QDEL's own stock, with no genuine read-through to diagnostics peers or a sector ETF.

At publish time: Headline is a rumored ($1.5B) asset sale sourced to an FT report and explicitly not finalized — a single-name, unconfirmed M&A number with no sector supply or capability change.

model confidence: high

What happened next

1–2 weeks later

no follow-up

No corpus follow-up on QDEL's carve-out; the two later items are unrelated divestitures (Continental/ContiTech, ITV/Sky), giving no read on QDEL's move.

based on follow-up coverage

Follow-up coverage

No follow-up coverage matched this story.

US Spot Bitcoin ETFs Extend Outflow Streak to Six Weeks With $227 Million Withdrawn U.S. Trade Deficit Widens to $105.8 Billion as Imports Rise and Exports Fall